Pieter Oldenziel active positions
Companies | Position | Start | End |
---|---|---|---|
ABLYNX | Director/Board Member | 01/01/2019 | - |
Sanofi Foreign Participations BV
Sanofi Foreign Participations BV Pharmaceuticals: GenericHealth Technology Part of Sanofi, Sanofi Foreign Participations BV is a Dutch company that manufactures human monoclonal antibody drugs. The company is based in Amsterdam, Netherlands. The company was founded in 1998. The CEO is Pieter Oldenziel. | Chief Executive Officer | - | - |
Career history of Pieter Oldenziel
Statistics
International
Belgium | 2 |
Netherlands | 2 |
Operational
Director/Board Member | 1 |
Chief Executive Officer | 1 |
Sectoral
Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
Ablynx NV
Ablynx NV BiotechnologyHealth Technology Ablynx NV operates as a clinical stage biopharmaceutical company, which engages in the development of proprietary therapeutic proteins under the Nanobodies brand. It includes haematology, inflammation, infectious disease, autoimmune disease, oncology and immune-oncology. The company was founded by Mark Vaeck in 2001 and is headquartered in Ghent, Belgium. | Health Technology |
Sanofi Foreign Participations BV
Sanofi Foreign Participations BV Pharmaceuticals: GenericHealth Technology Part of Sanofi, Sanofi Foreign Participations BV is a Dutch company that manufactures human monoclonal antibody drugs. The company is based in Amsterdam, Netherlands. The company was founded in 1998. The CEO is Pieter Oldenziel. | Health Technology |
- Stock Market
- Insiders
- Pieter Oldenziel
- Experience